Similar articles for PMID: 17344920

Year	Number of Results
1988	1
1989	1
1991	2
2000	1
2001	1
2002	2
2003	1
2004	4
2005	1
2006	4
2007	4
2008	1
2009	5
2010	1
2011	2
2012	2
2013	3
2014	1
2015	2
2024	0

1

Expression and mutation status of candidate kinases in multiple myeloma.

Claudio JO, Zhan F, Zhuang L, Khaja R, Zhu YX, Sivananthan K, Trudel S, Masih-Khan E, Fonseca R, Bergsagel PL, Scherer SW, Shaughnessy J, Stewart AK. Claudio JO, et al. Leukemia. 2007 May;21(5):1124-7. doi: 10.1038/sj.leu.2404612. Epub 2007 Mar 8. Leukemia. 2007. PMID: 17344920 No abstract available.

2

Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation.

McAuliffe S, Brown R, Catalano A, Ho PJ, Nassif N, Woodland N, Hart D, Weatherburn C, Yang S, Suen H, Paul C, Joshua D, Gibson J. McAuliffe S, et al. Leuk Lymphoma. 2015;56(9):2714-6. doi: 10.3109/10428194.2014.1003061. Epub 2015 Feb 17. Leuk Lymphoma. 2015. PMID: 25651422 No abstract available.

3

The fibroblast growth factors in multiple myeloma.

Krejci P, Mekikian PB, Wilcox WR. Krejci P, et al. Leukemia. 2006 Jun;20(6):1165-8. doi: 10.1038/sj.leu.2404202. Leukemia. 2006. PMID: 16598309 No abstract available.

4

Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.

Ronchetti D, Greco A, Compasso S, Colombo G, Dell'Era P, Otsuki T, Lombardi L, Neri A. Ronchetti D, et al. Oncogene. 2001 Jun 14;20(27):3553-62. doi: 10.1038/sj.onc.1204465. Oncogene. 2001. PMID: 11429702

5

Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis.

Soverini S, Terragna C, Testoni N, Ruggeri D, Tosi P, Zamagni E, Cellini C, Cavo M, Baccarani M, Tura S, Martinelli G. Soverini S, et al. Haematologica. 2002 Oct;87(10):1036-40. Haematologica. 2002. PMID: 12368157

6

Very low mutation frequency of exons 5-9 in the CARD11 gene from 186 adult acute leukemia and 31 multiple myeloma samples.

Kim MS, Yoo NJ, Lee SH. Kim MS, et al. Leuk Res. 2011 May;35(5):e46-7. doi: 10.1016/j.leukres.2010.11.017. Epub 2010 Dec 19. Leuk Res. 2011. PMID: 21176849 No abstract available.

7

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

Wood LD, Calhoun ES, Silliman N, Ptak J, Szabo S, Powell SM, Riggins GJ, Wang TL, Yan H, Gazdar A, Kern SE, Pennacchio L, Kinzler KW, Vogelstein B, Velculescu VE. Wood LD, et al. Hum Mutat. 2006 Oct;27(10):1060-1. doi: 10.1002/humu.9452. Hum Mutat. 2006. PMID: 16941478

8

A novel mutation involving the carboxy terminal region of the FGFR3 gene in a multiple myeloma patient with t(4;14).

Intini D, Baldini L, Lombardi L, Neri A. Intini D, et al. Leukemia. 2002 Jun;16(6):1201-2. doi: 10.1038/sj.leu.2402502. Leukemia. 2002. PMID: 12040455 No abstract available.

9

FGFR3 amplification in the absence of IGH@-FGFR3 fusion t(4;14) in myeloma.

Quintero-Rivera F, El-Sabbagh Badr R, Rao PN. Quintero-Rivera F, et al. Cancer Genet Cytogenet. 2009 Nov;195(1):92-3. doi: 10.1016/j.cancergencyto.2009.06.018. Cancer Genet Cytogenet. 2009. PMID: 19837276 No abstract available.

10

[Case report; A case of multiple myeloma which cells gained multiple gene and chromosome aberrations and changed their morphology to plasmablastoid and lymphoblastoid during less than two years course].

Tajika K, Okuyama N, Gomi S. Tajika K, et al. Nihon Naika Gakkai Zasshi. 2012 Nov 10;101(11):3236-8. doi: 10.2169/naika.101.3236. Nihon Naika Gakkai Zasshi. 2012. PMID: 23342598 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year